Paul N Durrington Selected Research

LDL glycated lipoproteins

1/2016	Diabetic dyslipidaemia.
8/2011	Susceptibility of LDL and its subfractions to glycation.
10/2010	Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes.
1/2009	Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul N Durrington Research Topics

Disease

28	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2004
19	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2004
15	Atherosclerosis 01/2022 - 08/2002
8	Coronary Disease (Coronary Heart Disease) 08/2015 - 08/2002
6	Obesity 01/2022 - 01/2008
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2006
5	Insulin Resistance 01/2022 - 01/2006
4	Weight Loss (Weight Reduction) 01/2022 - 01/2019
3	Albuminuria 01/2018 - 08/2004
2	Inflammation (Inflammations) 01/2022 - 01/2022
2	Morbid Obesity 03/2021 - 01/2021
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2020 - 04/2010
2	Glucose Intolerance 01/2019 - 06/2005
2	Hypertriglyceridemia 01/2016 - 02/2005
2	Hypertension (High Blood Pressure) 01/2016 - 08/2004
2	Neoplasms (Cancer) 09/2008 - 04/2006
1	Necrosis 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2021
1	Proteinuria 01/2018
1	Infections 08/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2014
1	Insulinoma 06/2014
1	Atherosclerotic Plaque (Atheroma) 01/2012
1	Carotid Artery Diseases 11/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2009
1	Disease Progression 11/2009
1	Overweight 11/2009
1	Abdominal Obesity 11/2009
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2009
1	Diabetes Mellitus 03/2009
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 10/2008
1	Myalgia 09/2008
1	IGA Glomerulonephritis (IGA Nephropathy) 11/2006
1	Lipodystrophy 08/2006
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2006
1	Hyperinsulinism (Hyperinsulinemia) 01/2006
1	Placental Insufficiency 08/2005

Drug/Important Bio-Agent (IBA)

19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 08/2004
15	oxidized low density lipoproteinIBA 01/2022 - 01/2004
13	LDL CholesterolIBA 01/2022 - 05/2004
10	HDL CholesterolIBA 01/2021 - 03/2009
9	Atorvastatin (Lipitor)FDA Link 01/2018 - 08/2004
8	Lipoproteins (Lipoprotein)IBA 01/2022 - 08/2005
7	CholesterolIBA 01/2022 - 03/2009
7	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022 - 08/2002
7	LipidsIBA 01/2022 - 08/2004
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 05/2004
5	Insulin (Novolin)FDA Link 01/2019 - 01/2006
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 01/2004
4	Apolipoproteins B (ApoB)IBA 01/2022 - 10/2008
4	C-Reactive ProteinIBA 01/2022 - 11/2009
4	LDL glycated lipoproteinsIBA 01/2016 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 08/2015
3	CytokinesIBA 01/2019 - 01/2008
3	ApolipoproteinsIBA 08/2011 - 10/2008
3	VitaminsIBA 01/2004 - 08/2002
3	AntioxidantsIBA 01/2004 - 08/2002
2	AutoantibodiesIBA 01/2022 - 06/2014
2	HDL LipoproteinsIBA 01/2022 - 11/2003
2	Lipoprotein(a)IBA 03/2021 - 08/2014
2	low density lipoprotein inhibitorIBA 03/2013 - 10/2010
2	AdiponectinIBA 08/2011 - 06/2006
2	Proteins (Proteins, Gene)FDA Link 08/2006 - 11/2003
2	EnzymesIBA 03/2006 - 08/2002
2	Lipid PeroxidesIBA 12/2002 - 08/2002
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	AntibodiesIBA 01/2022
1	1-penicillamyl-Leu(2)- oxytocinIBA 03/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	PCSK9 InhibitorsIBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	AlbuminsIBA 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	CreatinineIBA 01/2018
1	Apolipoprotein C-IIIIBA 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2016
1	OrganophosphatesIBA 08/2015
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Zinc Transporter 8IBA 06/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012
1	Ezetimibe (Zetia)FDA Link 04/2010
1	Colesevelam Hydrochloride (Welchol)FDA Link 04/2010
1	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2009
1	Oral ContraceptivesIBA 11/2009
1	Hormones (Hormone)IBA 11/2009
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 08/2006
1	Lamin Type A (Lamin A)IBA 08/2006
1	FatsIBA 04/2006
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2006
1	SteroidsIBA 01/2006
1	Glucose (Dextrose)FDA LinkGeneric 01/2006
1	Adenosine Triphosphate (ATP)IBA 01/2006

Therapy/Procedure

12	Therapeutics 01/2022 - 08/2004
7	Bariatric Surgery 01/2022 - 01/2019
1	Aftercare (After-Treatment) 01/2020